These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 27638852)
1. The association of ACE gene polymorphism with diabetic kidney disease and renoprotective efficacy of valsartan. Wang Y; Peng W; Zhang X; Qiao H; Wang L; Xu Z; Wu C J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27638852 [TBL] [Abstract][Full Text] [Related]
11. Polymorphism of the ACE Gene in dialysis patients: overexpression of DD genotype in type 2 diabetic end-stage renal failure patients. Park HC; Choi SR; Kim BS; Lee TH; Kang BS; Choi KH; Lee HY; Han DS; Ha SK Yonsei Med J; 2005 Dec; 46(6):779-87. PubMed ID: 16385653 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme (ACE) gene II genotype protects against the development of diabetic peripheral neuropathy in type 2 diabetes mellitus. Mansoor Q; Javaid A; Bilal N; Ismail M J Diabetes; 2012 Sep; 4(3):257-61. PubMed ID: 22607040 [TBL] [Abstract][Full Text] [Related]
13. The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria. Rahimi Z; Felehgari V; Rahimi M; Mozafari H; Yari K; Vaisi-Raygani A; Rezaei M; Malek-Khosravi S; Khazaie H Mol Biol Rep; 2011 Mar; 38(3):2117-23. PubMed ID: 20853144 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme gene polymorphism and vascular manifestations in Korean patients with SLE. Uhm WS; Lee HS; Chung YH; Kim TH; Bae SC; Joo KB; Kim TY; Yoo DH Lupus; 2002; 11(4):227-33. PubMed ID: 12043886 [TBL] [Abstract][Full Text] [Related]
15. Frequency of angiotensin-converting enzyme gene polymorphism in Turkish type 2 diabetic patients. Degirmenci I; Kebapci N; Basaran A; Efe B; Gunes HV; Akalin A; Kurt H; Urhan M; Demirustu C Int J Clin Pract; 2005 Oct; 59(10):1137-42. PubMed ID: 16178979 [TBL] [Abstract][Full Text] [Related]
16. Renoprotective efficacy of valsartan in chronic non-diabetic proteinuric nephropathies with renin-angiotensin system gene polymorphisms. Lee YJ; Jang HR; Kim SG; Chae DW; Do JY; Lee JE; Huh W; Kim DJ; Oh HY; Kim YG Nephrology (Carlton); 2011 Jul; 16(5):502-10. PubMed ID: 21303424 [TBL] [Abstract][Full Text] [Related]
17. The DD genotype of the ACE gene polymorphism is associated with diabetic nephropathy in the type-1 diabetics. Azar ST; Zalloua PA; Medlej R; Halabi G Endocr Res; 2001; 27(1-2):99-108. PubMed ID: 11428725 [TBL] [Abstract][Full Text] [Related]
18. [Angiotensin converting enzyme gene polymorphism and type 2 diabetic nephropathy]. Liao L; Lei MX; Chen HL Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):553-6. PubMed ID: 15804059 [TBL] [Abstract][Full Text] [Related]
19. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy. Ezzidi I; Mtiraoui N; Kacem M; Chaieb M; Mahjoub T; Almawi WY Diabetes Metab Res Rev; 2009 Nov; 25(8):717-24. PubMed ID: 19787680 [TBL] [Abstract][Full Text] [Related]
20. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy. Ahluwalia TS; Ahuja M; Rai TS; Kohli HS; Bhansali A; Sud K; Khullar M DNA Cell Biol; 2009 Mar; 28(3):141-50. PubMed ID: 19108684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]